• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 mRNA 递送至增强癌症免疫疗法的脂质纳米颗粒。

Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.

机构信息

Engineering Research Center of Nano-Geomaterials of Ministry of Education, Faculty of Materials Science and Chemistry, China University of Geosciences, Wuhan 430074, China.

School of Medicine, College of Chemistry, Nankai University, Tianjin 300071, China.

出版信息

Molecules. 2022 Aug 31;27(17):5607. doi: 10.3390/molecules27175607.

DOI:10.3390/molecules27175607
PMID:36080373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9458026/
Abstract

Messenger RNA (mRNA) is being developed by researchers as a novel drug for the treatment or prevention of many diseases. However, to enable mRNA to fully exploit its effects in vivo, researchers need to develop safer and more effective mRNA delivery systems that improve mRNA stability and enhance the ability of cells to take up and release mRNA. To date, lipid nanoparticles are promising nanodrug carriers for tumor therapy, which can significantly improve the immunotherapeutic effects of conventional drugs by modulating mRNA delivery, and have attracted widespread interest in the biomedical field. This review focuses on the delivery of mRNA by lipid nanoparticles for cancer treatment. We summarize some common tumor immunotherapy and mRNA delivery strategies, describe the clinical advantages of lipid nanoparticles for mRNA delivery, and provide an outlook on the current challenges and future developments of this technology.

摘要

信使 RNA(mRNA)正被研究人员开发为一种新型药物,用于治疗或预防许多疾病。然而,为了使 mRNA 能够充分发挥其在体内的作用,研究人员需要开发更安全、更有效的 mRNA 传递系统,以提高 mRNA 的稳定性并增强细胞摄取和释放 mRNA 的能力。迄今为止,脂质纳米颗粒是用于肿瘤治疗的有前途的纳米药物载体,通过调节 mRNA 的传递,可以显著提高常规药物的免疫治疗效果,在生物医学领域引起了广泛的关注。本综述重点介绍了脂质纳米颗粒在癌症治疗中的 mRNA 传递。我们总结了一些常见的肿瘤免疫治疗和 mRNA 传递策略,描述了脂质纳米颗粒用于 mRNA 传递的临床优势,并对该技术目前的挑战和未来的发展进行了展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/7d1a330a4ccc/molecules-27-05607-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/72541bfd3672/molecules-27-05607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/bc55b0ad3d0c/molecules-27-05607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/807373cdb632/molecules-27-05607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/04a6172ef1ad/molecules-27-05607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/85eedeb43fbf/molecules-27-05607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/a10673173283/molecules-27-05607-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/7d1a330a4ccc/molecules-27-05607-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/72541bfd3672/molecules-27-05607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/bc55b0ad3d0c/molecules-27-05607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/807373cdb632/molecules-27-05607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/04a6172ef1ad/molecules-27-05607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/85eedeb43fbf/molecules-27-05607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/a10673173283/molecules-27-05607-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df20/9458026/7d1a330a4ccc/molecules-27-05607-g007.jpg

相似文献

1
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.用于 mRNA 递送至增强癌症免疫疗法的脂质纳米颗粒。
Molecules. 2022 Aug 31;27(17):5607. doi: 10.3390/molecules27175607.
2
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond.mRNA 递药系统在癌症免疫治疗中的应用:脂质纳米粒及其他方法
Adv Drug Deliv Rev. 2024 Mar;206:115190. doi: 10.1016/j.addr.2024.115190. Epub 2024 Feb 1.
3
Development and applications of mRNA treatment based on lipid nanoparticles.基于脂质纳米粒的 mRNA 治疗的开发和应用。
Biotechnol Adv. 2023 Jul-Aug;65:108130. doi: 10.1016/j.biotechadv.2023.108130. Epub 2023 Mar 17.
4
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy.mRNA 靶向递送至免疫细胞以增强癌症治疗的进展。
Theranostics. 2024 Sep 3;14(14):5528-5550. doi: 10.7150/thno.93745. eCollection 2024.
5
Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.脂质纳米颗粒 mRNA 疗法在 COVID-19 疫苗之外的进展。
Nanoscale. 2024 Apr 4;16(14):6820-6836. doi: 10.1039/d4nr00019f.
6
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy.脂质纳米颗粒 (LNP) 可实现癌症治疗的 mRNA 递送。
Adv Mater. 2023 Dec;35(51):e2303261. doi: 10.1002/adma.202303261. Epub 2023 Nov 1.
7
mRNA delivery technologies: Toward clinical translation.mRNA 递送技术:迈向临床转化。
Int Rev Cell Mol Biol. 2022;372:207-293. doi: 10.1016/bs.ircmb.2022.04.010. Epub 2022 Jul 7.
8
Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.非病毒 mRNA 递药材料的研究进展及其作为黑素瘤治疗疫苗的应用
ACS Appl Bio Mater. 2024 Aug 19;7(8):4894-4913. doi: 10.1021/acsabm.3c00721. Epub 2023 Nov 6.
9
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.基于纳米颗粒的药物传递系统增强实体瘤中的癌症免疫治疗。
Front Immunol. 2023 Aug 3;14:1230893. doi: 10.3389/fimmu.2023.1230893. eCollection 2023.
10
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment.纳米颗粒基 mRNA 递送至癌症治疗的范围和挑战。
Arch Pharm Res. 2022 Dec;45(12):865-893. doi: 10.1007/s12272-022-01418-x. Epub 2022 Nov 24.

引用本文的文献

1
Updates on cancer vaccines in brain cancer: Advances in neuroblastoma, delivery systems, and emerging technologies.脑癌中癌症疫苗的最新进展:神经母细胞瘤、递送系统及新兴技术方面的进展
Hum Vaccin Immunother. 2025 Dec;21(1):2526964. doi: 10.1080/21645515.2025.2526964. Epub 2025 Jul 8.
2
From Microbial Ecology to Clinical Challenges: The Respiratory Microbiome's Role in Antibiotic Resistance.从微生物生态学到临床挑战:呼吸道微生物群在抗生素耐药性中的作用
Pathogens. 2025 Apr 5;14(4):355. doi: 10.3390/pathogens14040355.
3
Diverse nanoparticles deliver mRNA to enhance tumor immunotherapy.

本文引用的文献

1
The clinical progress of mRNA vaccines and immunotherapies.mRNA 疫苗和免疫疗法的临床进展。
Nat Biotechnol. 2022 Jun;40(6):840-854. doi: 10.1038/s41587-022-01294-2. Epub 2022 May 9.
2
Don't blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic.别怪信使:新冠疫情期间癌症mRNA疫苗的经验教训
Nat Rev Cancer. 2022 Jun;22(6):317-318. doi: 10.1038/s41568-022-00463-4.
3
Structure-activity relationships of pH-responsive and ionizable lipids for gene delivery.pH 响应性和可离子化脂质的结构-活性关系及其在基因传递中的应用。
多种纳米颗粒递送信使核糖核酸以增强肿瘤免疫疗法。
BMB Rep. 2025 Mar;58(3):124-132. doi: 10.5483/BMBRep.2024-0165.
4
Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment.用于癌症治疗中激活STING的环状二核苷酸的新型修饰和递送方式
Int J Nanomedicine. 2025 Jan 6;20:181-197. doi: 10.2147/IJN.S503780. eCollection 2025.
5
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture Medium.脂质体、金纳米颗粒和硒纳米颗粒中包封的环糊精对细胞培养基中siRNA稳定性的影响。
Pharmaceuticals (Basel). 2024 Oct 8;17(10):1344. doi: 10.3390/ph17101344.
6
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.治疗性癌症疫苗的最新研究成果:最新综述
Biomolecules. 2024 Apr 21;14(4):503. doi: 10.3390/biom14040503.
7
Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies.HPV 相关恶性肿瘤的 mRNA 治疗性疫苗的免疫原性和有效性。
Life Sci Alliance. 2024 Mar 21;7(6). doi: 10.26508/lsa.202302448. Print 2024 Jun.
8
Breaking genetic shackles: The advance of base editing in genetic disorder treatment.打破基因枷锁:碱基编辑在遗传疾病治疗中的进展。
Front Pharmacol. 2024 Mar 6;15:1364135. doi: 10.3389/fphar.2024.1364135. eCollection 2024.
9
Uncovering the Emerging Prospects of Lipid-based Nanoparticulate Vehicles in Lung Cancer Management: A Recent Perspective.揭示基于脂质的纳米颗粒载体在肺癌治疗中的新兴前景:近期观点
Pharm Nanotechnol. 2025;13(1):155-170. doi: 10.2174/0122117385286781240228060152.
10
Moving beyond traditional therapies: the role of nanomedicines in lung cancer.超越传统疗法:纳米药物在肺癌治疗中的作用
Front Pharmacol. 2024 Feb 8;15:1363346. doi: 10.3389/fphar.2024.1363346. eCollection 2024.
Int J Pharm. 2022 Apr 5;617:121596. doi: 10.1016/j.ijpharm.2022.121596. Epub 2022 Feb 16.
4
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy.联合 p53 mRNA 纳米治疗与免疫检查点阻断重编程免疫微环境以实现有效的癌症治疗。
Nat Commun. 2022 Feb 9;13(1):758. doi: 10.1038/s41467-022-28279-8.
5
Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform.载多柔比星和 PD-L1siRNA 的树状聚合物-脂质体纳米平台用于乳腺癌的联合化化疗免疫治疗
ACS Appl Mater Interfaces. 2022 Feb 23;14(7):8782-8792. doi: 10.1021/acsami.1c21775. Epub 2022 Feb 9.
6
Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung delivery application of mRNAs.新型易水解阳离子脂质的合成及其生物活性研究,用于潜在的 mRNA 肺部递药应用。
Chem Phys Lipids. 2022 Mar;243:105178. doi: 10.1016/j.chemphyslip.2022.105178. Epub 2022 Feb 3.
7
Opportunities and Challenges for mRNA Delivery Nanoplatforms.mRNA 递送纳米平台的机遇与挑战。
J Phys Chem Lett. 2022 Feb 10;13(5):1314-1322. doi: 10.1021/acs.jpclett.1c03898. Epub 2022 Feb 2.
8
Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.系统给予脂质纳米粒以递送修饰的 mRNA 至损伤的心肌。
J Control Release. 2022 Mar;343:207-216. doi: 10.1016/j.jconrel.2022.01.027. Epub 2022 Jan 22.
9
Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.开发高通量平台筛选用于 mRNA 递送的脂质纳米颗粒。
Nanoscale. 2022 Jan 27;14(4):1480-1491. doi: 10.1039/d1nr06858j.
10
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16 cancer.局部放疗和 E7 RNA-LPX 疫苗接种在 HPV16 癌症的临床前模型中显示出增强的治疗效果。
Cancer Immunol Immunother. 2022 Aug;71(8):1975-1988. doi: 10.1007/s00262-021-03134-9. Epub 2021 Dec 31.